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Abstract
Infectious diseases after spinal cord injury (SCI) are important. They can cause mortality 
and morbidity. The SCI patients usually stay in hospital or rehabilitation units for a long 
time, and this can cause several complications for them.
Infectious complications: There are several infectious complications in these patients. 
Pressure ulcers that may be infected, soft tissue infections, osteomyelitis, pneumonia, uri-
nary tract infection, bacteremia, meningitis, epidural abscess, and subdural empyema are 
important complications. These diseases should be diagnosed and managed promptly, 
before leading to irreversible complications or death.
Diagnosis: Diagnosis is made by physical examinations; laboratory tests like wound, 
urine, tracheal secretion, and blood culture with antibiogram; and radiologic evaluation 
like plain X-ray and magnetic resonance imaging may be used.
Treatment: Appropriate antibiotics are cornerstone of infectious complications. Offloading 
is important for treatment of pressure ulcers and subsequent complications such as soft 
tissue infection and osteomyelitis.
Prevention: Intermittent urinary catheterization and prophylactic antibiotic therapy can 
decrease UTI. Pressure relief, position changes, and regular and frequent observation of 
skin will prevent pressure ulcers, soft tissue infections, and osteomyelitis. Pulmonary 
toilet, appropriate positioning, and cough assistance can be useful for clearing retained 
secretions and preventing pneumonia.
Keywords: infectious, spinal cord, complications
1. Introduction
Infectious complications are supposed to be an important cause of morbidity and mortality 
in patients with spinal cord injury (SCI). Infectious diseases may lead to death and several 
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complications such as prolonged hospital stay and increased cost of management of patients. 
Several organs may be affected and problems in these organs can be even more important than 
the primary event. The types of infections in these patients are different and related to several 
factors. Inabilities to changing position or ineffective cough, using several necessary devices, 
prolonged hospitalization, and several other factors, in patients with SCI, predispose them 
to different types of infections. Inability to walk, sit, or change position may lead to pressure 
ulcers, skin and soft tissue infection, and osteomyelitis. Reduced tissue perfusion increases the 
spinal cord-injured patient’s susceptibility to pressure ulcers [1] during the acute and rehabili-
tation phases, most frequently over bony prominences such as the sacrum, tuber ischii, heel, 
malleolus, and trochanter [2]. Physical and psychosocial elements such as nutrition, past history 
of pressure ulcers, and social supports can be important in developing ulcers [3]. Ineffective 
cough and retained pulmonary secretion may lead to pneumonia. Most of the patients need 
intubation in the course of hospitalization that predisposes them to ventilator-associated pneu-
monia. Ventilator-associated pneumonia is the most frequent nosocomial infection in patients 
receiving mechanical ventilation and contributes to a longer intensive care unit stay and high 
morbidity and mortality [4, 5]. Use of high doses of corticosteroid for management of some 
patients with SCI can increase the risk of infection. In those patients who need surgical inter-
vention, the operation time is usually prolonged. Sometimes, the use of an external device is 
mandatory for fixation of unstable vertebral column. The SCI patients may develop blood-
stream infection during the hospital admission. During bloodstream infection occurrence in 
an SCI population, multidrug-resistant organisms are frequent [6]. ICU-acquired bloodstream 
infection in the intensive care unit is still associated with a high mortality rate. The increase of 
antimicrobial drug resistance makes its treatment increasingly challenging. ICU bloodstream 
infection is associated with a 40% increase in the risk of 30-day mortality, particularly if the 
early antimicrobial therapy is not adequate [7]. Paying attention to antibiotic therapy is impor-
tant in SCI patients. Antibiotic resistance is of great concern for both infection control and 
the treatment of infectious diseases. Drug-resistant pathogens, such as methicillin-resistant 
Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Acinetobacter and extended-spectrum 
β-lactamase (ESBL)-producing Enterobacteriaceae, are associated with inappropriate antibiotic 
treatment that resulted in adverse outcomes. In addition, unnecessary use of broad-spectrum 
antibiotics for patients with non-drug-resistant pathogens increases mortality [8].
These can be the risk factors for developing infections in SCI patients. In this chapter, the cause 
of infections, predisposing factors, diagnosis, management, and prevention will be discussed.
2. Infectious diseases after spinal cord injury
2.1. Urinary tract infection
Urinary tract infections (UTI) still cause significant morbidity in patients with spinal cord 
injury, although mortality due to urinary tract complications has decreased dramatically [9]. 
Patients with spinal cord injuries (SCIs) and complete or incomplete paraplegia are prone 
to frequent, recurrent, or chronic UTI. The reason for the increased risk of acquiring UTI is 
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multifactorial, including reduced sensation of classical UTI symptoms, incomplete bladder 
emptying, frequent catheterizations, or chronic urinary tract catheters [10]. The rate of UTI in 
an SCI patient is 2.5 episodes in patient per year. UTI is the second leading cause of mortality 
in SCI patients [11]. Patients with SCI who have urinary catheters have an increased risk of 
UTI. Urinary tract infection can be important and can cause serious complications including 
sepsis and septic shock if it is not diagnosed and treated.
Using Foley catheter is usually accompanied with colonization of microorganisms and 
infection [12]. Bacterial biofilm formation of Foley catheter can cause cystitis [10]. About 
80% of UTIs follow urinary catheter insertion. Nitrofurazone-coated and silver alloy-
coated catheters can decrease asymptomatic bacteriuria during short-term (<30 days) 
use in comparison with latex or silicon catheters. The risk of infection is higher with 
long-term catheterization, and it is safe to remove it early after surgery. Latex and sili-
cone catheters have the same infection rates, but Foley catheters cause more symptomatic 
bacteriuria and UTI than intermittent catheterizations. Changing the drainage bags and 
adding antiseptic solution to bags cannot prevent UTI in patients [13]. There are several 
risk factors for UTI in SCI patients. Reflux of vesicoureteral, postvoiding residuals, out-
let obstruction, urinary tract stones, and bladder overdistension [14]. These patients are 
exposed to antibiotics because of frequent infections that may be an important risk factor 
for resistant microorganism infection [15]. Today, UTI may be difficult to treat in SCI 
patients because of antibiotic-resistant organisms. The SCI patients are also colonized by 
resistant organisms because of recurrent and prolonged hospitalization [16]. The main 
causative agent of UTI in SCI population is usually derived from the patient’s flora. The 
indwelling catheter has a great role in infection and the duration of catheterization is 
the most important risk factor. If the patient carries a catheter more than 30 days, the 
risk of infection with multiple organisms will increase. Although short-term catheteriza-
tion can be risk factor for bacteriuria, it is usually asymptomatic and often by a single 
microorganism [17]. It is better to use hydrophilic-coated catheter for intermittent cath-
eterization in SCI patients during acute inpatient rehabilitation. These kinds of catheters 
can postpone the development of UTI. They also reduce the incidence of bacteriuria and 
infection. Reduction of complications and treatment costs and preventing the emergence 
of antibiotic-resistant organisms are other benefits of hydrophilic-coated catheters [18]. 
Substitution of indwelling catheter with intermittent catheterization during the rehabili-
tation phase will reduce development of UTI [9]. The unitary catheter should work in a 
closed system so that no organism can enter the system. It is also important to reduce 
the duration of catheterization. Sometimes intermittent catheterization, condom sheet 
catheter, and suprapubic catheters may substitute indwelling catheterization to reduce 
the risk of infection [17]. Intermittent catheterization is safe and is advised to prevent UTI 
in SCI patients. Condom sheet catheter can be used in patients who are able to urinate 
and there is no pathology or injury in urethra. In some patients, where using condom 
sheet catheter or intermittent catheterization is not suitable or possible, the physician 
may decide to use suprapubic catheter. The physicians should be aware of these two 
points that SCI patients may not have the classic symptoms of UTI and urinary infection 
may cause urologic complications [15].
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2.1.1. Diagnosis
Diagnosis of UTI is usually based on the results of urine culture, although in some condition 
like low titer of organism in urine, slow-growing pathogens and unusual organisms, results 
of culture may be unreliable [12]. The physician should be aware of how to diagnose UTI 
and distinguish it from colonization. These patients are at increased risk of acquiring multi-
drug-resistant bacteria because they are admitted due to UTI or other infectious diseases and 
take antibiotics. Several resistant organisms may cause UTI in SCI patients including mul-
tidrug-resistant Pseudomonas aeruginosa, ESBL (extended-spectrum β-lactamase-producing) 
Escherichia coli, resistant Klebsiella spp. and MRSA (methicillin-resistant Staphylococcus aureus) 
[10]. Due to multiple risk factors for acquisition of infection, especially with resistant organ-
isms, complicated UTI may develop with unusual and resistant bacteria. The infection may 
be polymicrobial. Proteus, Providencia, Serratia, and enterococci may also cause UTI in these 
groups [9]. For the diagnosis of UTI, culture is needed to find to causative agent, but if the 
patient is not symptomatic, it is not necessary to get culture, because the patients usually do 
not need treatment [17]. When UTI is diagnosed in SCI patient, the physician should evaluate 
the patient for anatomical and functional disorders. It is important to correct any correctable 
disorder for optimal treatment success [9].
2.1.2. Treatment
Differentiating infection from colonization and asymptomatic bacteriuria from symptomatic 
infection is an important point in treatment of UTI in SCI patient. A symptomatic patient 
needs to be treated, and after treatment, long duration of antibiotic suppressive therapy 
is not necessary [17]. For treatment of UTI, usually, there are many antibiotic options. It is 
better to postpone the treatment until the result of culture. Sometimes it is necessary to treat 
the patient empirically. Some variables like probable organism and susceptibility, adminis-
tration route (oral vs. intravenous), the patient tolerance, renal function, and the patients’ 
other medications should be considered for choosing appropriate antibiotic [19]. Duration of 
treatment of chronic UTI in SCI patient may need to be extended. Some studies recommend 
and some do not. It seems more studies are needed for certain recommendations [10]. The 
best antibiotics are those that have the most therapeutic effect on causative agent, without 
any or with less impact on the host normal flora. This antibiotic is best chosen according to 
result of urine culture and antibiogram. Duration of treatment is usually 5 days but may 
be extended to 7–14 days when reinfection or relapse occurs [9]. Some studies recommend 
treating urinary infection between 10 and 14 days in SCI patients, especially when it is not 
possible to discontinue the urinary catheter. To determine the optimal duration of treatment, 
multicentral and randomized clinical trial may be necessary [19]. Darouiche’s study demon-
strates that the 5-day treatment with urinary catheter exchange can be as effective as a 10-day 
regimen with catheter retention [20]. Antibiotics usually are chosen according to urine cul-
ture. Third generation of cephalosporines, carbapenems, and quinolones are often used to 
treat Gram-negative organisms. For treatment of Enterococcus and Staphylococcus aureus that 
usually are resistant in these patients (i.e., methicillin-resistant S. aureus or MRSA), vanco-
mycin is appropriate.
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2.1.3. Prevention and prophylaxis
Prevention of UTI in SCI patients plays an important role in hospital and even in rehabilitation 
courses of these patients. Paying attention to urinary tract hygiene is necessary. Some patients 
may encounter relapse or reinfection. In these patients, evaluation of structural and functional 
disorders should be performed. Duration of previous treatment and probable complications 
like urine residue and urinary stone should be assessed. Antibiotics may be used as prophy-
laxis, but it is important to notice that it can be used when recurrent UTI occurs and when all 
structural and functional abnormalities are corrected. Prophylaxis is not recommended for 
patients carrying indwelling catheters, and for those who have intermittent catheterization, 
it is contraventional [9]. Physicians can most effectively prevent UTI by avoiding use of long-
term catheters, short duration of catheter use, and substituting intermittent catheterization 
with indwelling catheter. Daily washing of the catheter or perianal or periurethral areas has 
no preventive effect. It is recommended to use antibiotic immediately before any invasive 
procedure on urinary tract system [19]. Probiotics may be useful as prophylactic agents. They 
may decrease the number of resistant organisms’ colonization and may be an attractive sub-
stitution for antibiotics for prophylaxis in future [16]. Non-antibiotic prophylaxis may be used 
for preventing UTI. Some studies may recommend cranberry juice as prophylaxis of UTI, but 
there is not any reliable clue to prove its effectiveness [9]. In Linsenmeyer’s study, cranberry 
was used for prophylaxis of UTI in patients with neurogenic bladder after spinal cord injury. 
Cranberry tablets could not effectively decrease the risk of UTI in patients with neurogenic 
bladders [21].
2.2. Skin and soft tissue infection
One of the most important, serious, and chronic complications of spinal cord injury is pressure 
ulcer [22]. Pressure ulcers may cause long-term morbidity and even mortality and effectively 
have severe influence on SCI patients’ lives [23]. These patients have more risk of developing 
pressure ulcer. The ulcers are often chronic wounds that debilitate the patient and increase 
hospital course [24]. Pressure ulcers are common in SCI patients and usually are complicated. 
Treatment is often difficult and expensive. It is important to pay special attention to pressure 
ulcer in SCI population [25]. Several risk factors are associated with pressure ulcer. These risk 
factors include: decreased activity, complete cord injury that cause paralysis, cervical collar 
and back board that cause restricted activity, diabetes mellitus, cigarette smoking, hypoalbu-
minemia, nursing home residence or long duration hospital stay [26], loss of sensation, wet 
area due to urinary or fecal incontinence, poor nutrition, and muscular atrophy. Pressure 
ulcers usually occur in about 30–40% of SCI patients. Ulcers usually develop on bony promi-
nences. Sacrum, ischial tuberosity, trochanteric area and malleolus are usual areas for devel-
oping ulcers [2]. Patients with pressure ulcers may have good outcomes if rapid diagnosis 
and proper treatment is performed for them. The ulcer may heal completely without any 
sequelae. Some ulcers may have slow course of healing and some even may not heal. Some 
studies emphasize on the role of fibronectin on ulcer healing course. Fibronectin may have 
a role in opsonizing macro-aggregate debris for phagocytosis, increasing revascularization, 
and facilitating fibroblast proliferation and migration. Plasma fibronectin increases in ulcers 
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with rapid healing but stay in low level in ulcers with poor healing. So plasma fibronectin 
level may predict the speed of healing of pressure ulcers [27]. The SCI patients may also suf-
fer from other soft tissue infection rather than pressure ulcers including fungal infections and 
seborrheic dermatitis [28].
2.2.1. Diagnosis
Diagnosis of pressure ulcers is clinical. The ulcer smear and culture can be useful for recogniz-
ing the causative organism and determining the antibiotic sensitivity. Staphylococcus aureus, 
Pseudomonas aeruginosa, Proteus mirabilis, and Enterococcus faecalis are the most common organ-
isms causing pressure ulcers [24].
2.2.2. Treatment
Offloading is the cornerstone of treatment of pressure ulcers. Ultrasound (low-frequency and 
nonthermal) may have a therapeutic role in intact skin ulcers. If the ulcer is superficial, foam 
dressing and collagenase may be used. For deep pressure ulcers, usually debridement and 
surgical intervention is needed. Osteomyelitis beneath the ulcer is so important and should 
be considered in treatment of deep ulcers [23]. In SCI patients, flap surgery may be needed 
to cover the place of debridement [25]. In Schryvers’s study on large number of SCI patients 
with pressure ulcers during 20 years, a large number of patients needed surgical intervention. 
Pelvic area ulcers were the most common (468 of 598 pressure ulcers), of which 431 (92%) 
were treated surgically. Fasciocutaneous or cutaneous flaps, muscle or musculocutaneous 
flaps and primary closures were the most common surgical intervention. During the ulcer 
management, some bone intervention is unavoidable [29]. Medical honey has a substantial 
efficacy on wound management and control of infection of pressure ulcer, as shown by low 
bacterial growth, decreased wound size, and improved healing stage [30].
Electric stimulation therapy (EST) accelerates pressure ulcer healing in SCI patients. Pressure 
ulcer healing is determined by decrease in wound size and improvement in wound appear-
ance after 3 months of treatment with EST [31]. Use of ultraviolet light C (light wavelength 
200–290 nm) may be effective in treatment. It can be because of its potency in killing anti-
biotic-resistant microorganisms. Staphylococcus aureus, methicillin-resistant Staphylococcus 
aureus (MRSA) and Pseudomonas aeruginosa that may be resident on superficial layer of wound 
may be killed by ultraviolet light C [32]. Maggot therapy may also be used a subsidiary way 
to treat wound ulcer. Live blowfly larvae in wound dressings accelerate wound healing by 
increasing debridement. They can debride necrotic tissue within 1 week that is so rapid in 
nonsurgical wound management. It is safe, simple, and inexpensive, and it seems that it has 
no complications, so it can be used for treatment of pressure ulcers in SCI patients [33].
2.2.3. Prevention
Pressure ulcers certainly have a great influence on daily activity and life of SCI patients [34]. 
The best position and the turning frequency are not clear, but avoiding the 90° lateral posi-
tion is recommended. This position will bring about high pressure over the trochanters with 
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the risk of pressure ulcer development. The risk of developing pressure ulcer is highly indi-
vidualized and the SCI patient is at a significant risk. Prevention strategies in seating position 
and in bed are very important in this group to prevent pressure ulcer, and so, pressure relief 
maneuvers can be important [35]. Pressure relief, position changes, and regular and frequent 
observation of skin, especially on the pressure areas, that is, over the bony prominences can 
prevent pressure ulcer development [2]. Pressure ulcers can also be prevented by improve-
ment of neurologic functions and reducing the time of hospitalization and rehabilitation stay 
[36]. Pressure ulcer prevention is strongly associated with lifestyle modification [35]. Frequent 
change of position and use of pressure-relieving devices have important roles in reducing 
the pressure ulcer development. Some risk factors other than pressure may be important in 
developing ulcer. In SCI patients who do not have vasomotor control below the level of the 
lesion, hypoxemia will develop, and it can be an important risk factor. So, pressure ulcers may 
be prevented not only by reducing external pressure by pressure relief, but also by increasing 
the patient’s resistance to pressure, by increasing tissue oxygenation [37]. One of the impor-
tant risk factors that may increase skin and soft tissue infections is resistant bacterial coloni-
zation. Some activities such as hand hygiene, contact precautions, and cultural changes are 
associated with significant declines in bacterial infection, especially MRSA colonization and 
infection [28].
2.3. Osteomyelitis
One of the complications of spinal cord injury is osteomyelitis. Osteomyelitis may develop by 
extension of infection from pressure ulcers [38]. After spinal fixation surgery, osteomyelitis 
may be developed, as a complication of surgery. Osteomyelitis increases the treatment cost 
and may lead to other complications [39].
2.3.1. Diagnosis
There are several diagnostic methods for diagnosis of osteomyelitis in SCI patients.
Bone biopsy is the gold standard, and magnetic resonance imaging (MRI) is usually used as a sen-
sitive and specific modality. Several organisms are known as causative agents. The most common 
isolated organisms are Staphylococcus aureus, Peptostreptococcus, and Bacteroides. Coagulase-
negative staphylococci, group B Streptococcus, Proteus, and group milleri Streptococcus may 
also be isolated as less common agents. The diagnosis of pelvic osteomyelitis is difficult and 
may need multiple bone biopsies. At least three bone samples may be necessary to detect the 
pathogen and exclusion of contamination. In one study, sensitivity of MRI for diagnosis of pelvic 
pressure ulcer osteomyelitis was 94% and specificity was 22% [40].
However, Huang’s study demonstrates that MRI is a sensitive method for diagnosis of osteo-
myelitis in SCI population. MRI can be used to demonstrate the extension of infection and to 
guide limited surgical resection and preserve viable tissue [41]. Pelvic pressure ulcers that 
accompany osteomyelitis may show cortical erosion and bone marrow edema in MRI [42]. 
In SCI patients, abscesses, fluid collections, and sinus tracts can be detected by MRI [43]. For 
diagnosis of osteomyelitis, gallium scan and plain pelvis X-ray may be used. Negative bone 
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scan can rule out osteomyelitis. However, chronic ulcers usually accompany osteomyelitis. 
Delayed healing or recurrence of pressure ulcers has no clear association with osteomyelitis 
[44]. Computerized tomography and Technetium-99 m bone scans are not usually used for 
diagnosis of osteomyelitis in SCI patients with pressure sores [45].
2.3.2. Treatment
Treatment of osteomyelitis is composed of two parts: surgical management and medical treat-
ment. Surgical approach is in fact debridement and in some patients, muscle flap. Medical 
therapy is in fact antibiotic therapy and wound care. Hyperbaric oxygen may be used in 
refractory osteomyelitis [46]. Treatment of osteomyelitis is prolonged and so, expensive. 
Using surgical debridement can shorten the duration of antibiotic therapy for osteomyelitis in 
SCI patients. In SCI patients with bony prominence osteomyelitis, surgical debridement and 
flap coverage of the sore can influence the outcome of antibiotic treatment [47]. Antibiotics for 
treatment are chosen according to the results of culture.
2.3.3. Prevention
Measures for prevention of osteomyelitis are in fact those that were mentioned in Section 
2.3.1 for prevention of pressure ulcer and skin and soft tissue infection. The main preventive 
measures are pressure relief, regular change of position, and frequent observation of the skin 
over bony prominences.
2.4. Pneumonia
Pulmonary complications in SCI patients are important, as they may be life threatening. 
Pneumonia, pulmonary infarction, pulmonary thromboembolism, chest injury, and atelec-
tasis are the most frequent and important complications in these patients. Pneumonia is one 
of the most important pulmonary complications. It may have developed shortly after spinal 
cord injury, during hospitalization or even in rehabilitation periods. The risk of pneumonia is 
greater in post-injury period. In this phase, the patients usually do not have effective cough. 
If the phrenic and intercostal nerves have been damaged, the respiration cycle may be influ-
enced and the patients may be prone to pneumonia [48]. After intubation and mechanical 
ventilation, ventilator-associated pneumonia (VAP) may develop. VAP is in fact the occur-
rence of pneumonia in patients with mechanical ventilation, occurring more than 48 h after 
endotracheal intubation [49]. VAP is the most frequent nosocomial infection in patients with 
mechanical ventilation and is associated with longer intensive care unit stay, longer duration 
of mechanical ventilation, and high morbidity and mortality [4].
2.4.1. Diagnosis
Pneumonia is diagnosed by signs and symptoms of respiratory infection and according to cri-
teria for diagnosis of nosocomial pneumonia and VAP. By endotracheal culture, the causative 
organism is found and an antibiotic is chosen according to the result of culture. The most com-
mon organisms are Pseudomonas aeruginosa, Klebsiella pneumonia, Acinetobacter baumannii [50], 
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Serratia marcescens [51] and methicillin-resistant Staphylococcus aureus [52]. Chest radiograph 
accompanied by clinical and laboratory findings are required for diagnosis of patients with 
suspected VAP [53].
2.4.2. Treatment
Antibiotics are chosen according to endotracheal secretion culture. For empirical treatment, 
combination antibiotic therapy is necessary. In this combination, an anti-pseudomonas agent 
(that is usually effective on other gram negative organisms) such as imipenem, meropenem, 
piperacillin-tazobactam or cefepime in addition to an aminoglycoside or a quinolone is used. 
For coverage of Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin is usually 
added to this combination. For a special situation such as multidrug-resistant Acinetobacter 
or Pseudomona, the appropriate antibiotic (like colistin) is elected according to culture. The 
rising rates of antimicrobial resistance have led to the routine empiric administration of 
broad-spectrum antibiotics even when bacterial infection is not documented [52].
2.4.3. Prevention
One important risk factor for developing pneumonia is retained secretion. So, pulmonary 
toilet is important in these patients. Appropriate positioning and cough assistance can be use-
ful for clearing retained secretions. Sometimes early intubation may be necessary to prevent 
secretion retaining by frequent suctioning [48]. Using effective oral care with antiseptics is 
associated with the reduction of the incidence of ventilator-associated pneumonia. Oral care 
solutions have been widely used to prevent ventilator-associated pneumonia [49]. Routine 
cleaning and disinfection of ventilators can play an important role in VAP prevention and 
management approach [53].
2.5. Other infections
Blood stream infection secondary to urinary tract infections, pneumonia, pressure ulcers [48], 
catheter-related bloodstream infections [54], and infections at other sites may occur in SCI 
patients. Meningitis may occur after penetrating injuries or as a result of CSF leakage at the 
time of injury or subsequent to surgery [48]. Epidural abscess and subdural empyema can be 
developed with the same mechanisms. Ventilator-associated tracheobronchitis (VAT) is an 
infective complication of mechanical ventilation and is a part of the spectrum of ventilator-
associated respiratory infections [55].
3. Conclusion
Infectious diseases after spinal cord injury are important and should be considered in patients 
with fever and other signs and symptoms of infections. Appropriate approach, diagnosis, and 
treatment and surgical interventions, if needed, can be lifesaving and can decrease mortality 
and morbidity.
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